{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:10:37Z","timestamp":1773285037731,"version":"3.50.1"},"reference-count":117,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.mayocp.2014.04.018","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T12:00:16Z","timestamp":1403697616000},"page":"1436-1451","source":"Crossref","is-referenced-by-count":41,"title":["Hospitalist Perspective on the Treatment of Skin and Soft Tissue Infections"],"prefix":"10.1016","volume":"89","author":[{"given":"Alpesh N.","family":"Amin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Cerceo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven B.","family":"Deitelzweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Pile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley M.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.mayocp.2014.04.018_bib1","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/archinte.168.14.1585","article-title":"National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections","volume":"168","author":"Hersh","year":"2008","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2014.04.018_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.annemergmed.2007.12.004","article-title":"Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant","volume":"51","author":"Pallin","year":"2008","journal-title":"Staphylococcus aureus. Ann Emerg Med"},{"issue":"9","key":"10.1016\/j.mayocp.2014.04.018_bib3","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3201\/eid1509.081228","article-title":"Trends in US hospital admissions for skin and soft tissue infections","volume":"15","author":"Edelsberg","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2014.04.018_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diagmicrobio.2009.02.005","article-title":"The attributable clinical and economic burden of skin and skin structure infections in hospitalized patients: a matched cohort study","volume":"64","author":"Hatoum","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2014.04.018_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MD.0b013e3181e8d635","article-title":"The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation","volume":"89","author":"Jeng","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.mayocp.2014.04.018_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.diagmicrobio.2006.05.009","article-title":"Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)","volume":"57","author":"Moet","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2014.04.018_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1086\/367653","article-title":"Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection","volume":"36","author":"Engemann","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2014.04.018_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajic.2010.03.018","article-title":"Outcomes and management costs in patients hospitalized for skin and skin-structure infections","volume":"39","author":"Itani","year":"2011","journal-title":"Am J Infect Control"},{"issue":"3","key":"10.1016\/j.mayocp.2014.04.018_bib9","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocp.2014.04.018_bib10","series-title":"Teflaro [prescribing information]","year":"2012"},{"key":"10.1016\/j.mayocp.2014.04.018_bib11","series-title":"Tygacil [prescribing information]","year":"2013"},{"key":"10.1016\/j.mayocp.2014.04.018_bib12","series-title":"Vibativ [prescribing information]","year":"2013"},{"issue":"1","key":"10.1016\/j.mayocp.2014.04.018_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"issue":"10","key":"10.1016\/j.mayocp.2014.04.018_bib14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/497143","article-title":"Practice guidelines for the diagnosis and management of skin and soft-tissue infections","volume":"41","author":"Stevens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocp.2014.04.018_bib15","series-title":"Cleocin HCl [prescribing information]","year":"2013"},{"key":"10.1016\/j.mayocp.2014.04.018_bib16","series-title":"Cleocin phosphate [prescribing information]","year":"2013"},{"issue":"5","key":"10.1016\/j.mayocp.2014.04.018_bib17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/511638","article-title":"Necrotizing soft-tissue infection: diagnosis and management","volume":"44","author":"Anaya","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocp.2014.04.018_bib18","series-title":"Hospital Medicine","author":"Wachter","year":"2005"},{"issue":"6","key":"10.1016\/j.mayocp.2014.04.018_bib19","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/313525","article-title":"Cost-effectiveness of blood cultures for adult patients with cellulitis","volume":"29","author":"Perl","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2014.04.018_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archinte.1989.00390020039008","article-title":"Quantitative cultures of biopsy specimens from cutaneous cellulitis","volume":"149","author":"Duvanel","year":"1989","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2014.04.018_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S0950268809990483","article-title":"Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review","volume":"138","author":"Chira","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.mayocp.2014.04.018_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2036-7902-4-5","article-title":"Comparison of computerized tomography and ultrasound for diagnosing soft tissue abscesses","volume":"4","author":"Gaspari","year":"2012","journal-title":"Crit Ultrasound J"},{"issue":"8","key":"10.1016\/j.mayocp.2014.04.018_bib23","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ajem.2011.09.020","article-title":"The effect of bedside ultrasound on diagnosis and management of soft tissue infections in a pediatric ED","volume":"30","author":"Iverson","year":"2012","journal-title":"Am J Emerg Med"},{"issue":"7","key":"10.1016\/j.mayocp.2014.04.018_bib24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1553-2712.2005.tb00913.x","article-title":"ABSCESS: applied bedside sonography for convenient evaluation of superficial soft tissue infections","volume":"12","author":"Squire","year":"2005","journal-title":"Acad Emerg Med"},{"issue":"5","key":"10.1016\/j.mayocp.2014.04.018_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/archsurg.2010.50","article-title":"Diagnosis of necrotizing soft tissue infections by computed tomography","volume":"145","author":"Zacharias","year":"2010","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.mayocp.2014.04.018_bib26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1148\/radiol.11101164","article-title":"Can necrotizing infectious fasciitis be differentiated from nonnecrotizing infectious fasciitis with MR imaging?","volume":"259","author":"Kim","year":"2011","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.mayocp.2014.04.018_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2214\/ajr.170.3.9490940","article-title":"Differentiation of necrotizing fasciitis and cellulitis using MR imaging","volume":"170","author":"Schmid","year":"1998","journal-title":"AJR Am J Roentgenol"},{"issue":"suppl 4","key":"10.1016\/j.mayocp.2014.04.018_bib28","first-page":"iv17","article-title":"Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study","volume":"65","author":"Jones","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.mayocp.2014.04.018_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/mdr.2010.0193","article-title":"Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion","volume":"17","author":"Mera","year":"2011","journal-title":"Microbiol Drug Resist"},{"issue":"1","key":"10.1016\/j.mayocp.2014.04.018_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.diagmicrobio.2013.02.020","article-title":"Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant","volume":"76","author":"Ray","year":"2013","journal-title":"Staphylococcus aureus. Diagn Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.mayocp.2014.04.018_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.mayocp.2014.04.018_bib32","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa042683","article-title":"Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles","volume":"352","author":"Miller","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.mayocp.2014.04.018_bib33","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/648083","article-title":"Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors","volume":"30","author":"Zilberberg","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"33","key":"10.1016\/j.mayocp.2014.04.018_bib34","first-page":"793","article-title":"Methicillin-resistant Staphylococcus aureus infections among competitive sports participants\u2014Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.mayocp.2014.04.018_bib35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1503\/cmaj.051565","article-title":"Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration","volume":"175","author":"Gilbert","year":"2006","journal-title":"CMAJ"},{"issue":"14","key":"10.1016\/j.mayocp.2014.04.018_bib36","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa043252","article-title":"Methicillin-resistant Staphylococcus aureus disease in three communities","volume":"352","author":"Fridkin","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2014.04.018_bib37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/528716","article-title":"Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?","volume":"46","author":"Popovich","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2014.04.018_bib38","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/313461","article-title":"Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia","volume":"29","author":"Lina","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"suppl 4","key":"10.1016\/j.mayocp.2014.04.018_bib39","doi-asserted-by":"crossref","first-page":"S269","DOI":"10.1086\/430788","article-title":"Community-associated methicillin-resistant Staphylococcus aureus","volume":"41","author":"Weber","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"suppl 5","key":"10.1016\/j.mayocp.2014.04.018_bib40","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.1086\/533593","article-title":"Skin and soft-tissue infections caused by community-acquired methicillin-resistant","volume":"46","author":"Stryjewski","year":"2008","journal-title":"Staphylococcus aureus. Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.mayocp.2014.04.018_bib41","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1086\/507923","article-title":"Community-associated strains of methicillin-resistant Staphylococcus aureus as the cause of healthcare-associated infection","volume":"27","author":"Gonzalez","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.mayocp.2014.04.018_bib42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/499815","article-title":"Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections","volume":"42","author":"Seybold","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocp.2014.04.018_bib43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2334-12-154","article-title":"Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections","volume":"12","author":"Zilberberg","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2014.04.018_bib44","doi-asserted-by":"crossref","first-page":"e24326","DOI":"10.1371\/journal.pone.0024326","article-title":"Use of observation care in US emergency departments, 2001 to 2008","volume":"6","author":"Venkatesh","year":"2011","journal-title":"PLoS One"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2014.04.018_bib45","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkg466","article-title":"Managing skin and soft tissue infections: expert panel recommendations on key decision points","volume":"52","author":"Eron","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"suppl 2","key":"10.1016\/j.mayocp.2014.04.018_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/21548331.1993.11442940","article-title":"Outpatient parenteral antibiotic therapy: management of serious infections: part II, amenable infections and models for delivery: cellulitis","volume":"28","author":"Lindbeck","year":"1993","journal-title":"Hosp Pract (Off Ed)"},{"issue":"1","key":"10.1016\/j.mayocp.2014.04.018_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0733-8627(05)70175-9","article-title":"Management of patients with infectious diseases in an emergency department observation unit","volume":"19","author":"Roberts","year":"2001","journal-title":"Emerg Med Clin North Am"},{"issue":"2","key":"10.1016\/j.mayocp.2014.04.018_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12245-008-0029-z","article-title":"Predicting observation unit treatment failures in patients with skin and soft tissue infections","volume":"1","author":"Schrock","year":"2008","journal-title":"Int J Emerg Med"},{"issue":"2","key":"10.1016\/j.mayocp.2014.04.018_bib49","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ajem.2012.09.005","article-title":"Identifying patients with cellulitis who are likely to require inpatient admission after a stay in an ED observation unit","volume":"31","author":"Volz","year":"2013","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.mayocp.2014.04.018_bib50","series-title":"InterQual Level of Care Criteria 2013: Acute Care","year":"2013"},{"issue":"160","key":"10.1016\/j.mayocp.2014.04.018_bib51","first-page":"50495","volume":"78","year":"2013","journal-title":"Fed Regist"},{"key":"10.1016\/j.mayocp.2014.04.018_bib52","unstructured":"Centers for Medicare and Medicaid Service. Special Open Door Forum: Final Rule CMS 1599-F: Discussion of the Hospital Inpatient Admission Order and Certification; 2 Midnight Benchmark for Inpatient Hospital Admissions. http:\/\/www.cms.gov\/Outreach-and-Education\/Outreach\/OpenDoorForums\/Downloads\/121913SODFFinalRuleCMS1599F.pdf. Accessed December 3,\u00a02013."},{"issue":"5","key":"10.1016\/j.mayocp.2014.04.018_bib53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/sur.2009.012","article-title":"Treatment of complicated skin and soft tissue infections","volume":"10","author":"May","year":"2009","journal-title":"Surg Infect"},{"issue":"3","key":"10.1016\/j.mayocp.2014.04.018_bib54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1089\/sur.2012.103","article-title":"Initial treatment failure in patients with complicated skin and skin structure infections","volume":"14","author":"Berger","year":"2013","journal-title":"Surg Infect"},{"issue":"5","key":"10.1016\/j.mayocp.2014.04.018_bib55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/432473","article-title":"Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003","volume":"41","author":"Richter","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"suppl 3","key":"10.1016\/j.mayocp.2014.04.018_bib56","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1093\/cid\/cis560","article-title":"Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program","volume":"55","author":"Sader","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2014.04.018_bib57","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.amjsurg.2007.07.016","article-title":"Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy","volume":"194","author":"Awad","year":"2007","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.mayocp.2014.04.018_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/IPC.0b013e318279ee69","article-title":"Patterns of initial antibiotic therapy for complicated skin and skin structure infections (cSSSI) in US hospitals, 2000-2009","volume":"21","author":"Berger","year":"2013","journal-title":"Infect Dis Clin Pract"},{"issue":"5","key":"10.1016\/j.mayocp.2014.04.018_bib59","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","article-title":"Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection","volume":"117","author":"Markowitz","year":"1992","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.mayocp.2014.04.018_bib60","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/00006454-200212000-00014","article-title":"Periorbital versus orbital cellulitis","volume":"21","author":"Givner","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.mayocp.2014.04.018_bib61","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1086\/511872","article-title":"Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome","volume":"44","author":"Ruhe","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocp.2014.04.018_bib62","series-title":"Guidance for Industry: Acute Bacterial Skin and Skin Structure Infections: Developing Drugs for Treatment","year":"2013"},{"key":"10.1016\/j.mayocp.2014.04.018_bib63","series-title":"Cubicin [prescribing information]","year":"2012"},{"key":"10.1016\/j.mayocp.2014.04.018_bib64","series-title":"Vancomycin [prescribing information]","year":"2010"},{"key":"10.1016\/j.mayocp.2014.04.018_bib65","series-title":"Zyvox [prescribing information]","year":"2013"},{"issue":"9","key":"10.1016\/j.mayocp.2014.04.018_bib66","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1128\/AAC.00351-10","article-title":"Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States","volume":"54","author":"McDougal","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mayocp.2014.04.018_bib67","first-page":"347969","article-title":"Retrospective analysis of clinical and cost outcomes associated with methicillin-resistant Staphylococcus aureus complicated skin and skin structure infections treated with daptomycin, vancomycin, or linezolid","volume":"2011","author":"Wright","year":"2011","journal-title":"J\u00a0Pathog"},{"issue":"6","key":"10.1016\/j.mayocp.2014.04.018_bib68","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1345\/aph.1G728","article-title":"Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections","volume":"40","author":"McKinnon","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1016\/j.mayocp.2014.04.018_bib69","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1592\/phco.27.12.1611","article-title":"Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes","volume":"27","author":"Davis","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.mayocp.2014.04.018_bib70","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijantimicag.2011.09.028","article-title":"New insights into methicillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment\u00a0and resistance","volume":"39","author":"Gould","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"suppl 4","key":"10.1016\/j.mayocp.2014.04.018_bib71","first-page":"iv17","article-title":"Clinical activity of anti-Gram-positive agents against methicillin-resistant","volume":"66","author":"Gould","year":"2011","journal-title":"Staphylococcus aureus. J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.mayocp.2014.04.018_bib72","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1086\/587896","article-title":"Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms","volume":"46","author":"Stryjewski","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.mayocp.2014.04.018_bib73","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40265-013-0075-6","article-title":"Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia","volume":"73","author":"Frampton","year":"2013","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.mayocp.2014.04.018_bib74","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1086\/518452","article-title":"Counterpoint: vancomycin and Staphylococcus aureus\u2014an antibiotic enters obsolescence","volume":"44","author":"Deresinski","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2014.04.018_bib75","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1086\/422458","article-title":"Staphylococcus aureus with reduced susceptibility to vancomycin","volume":"39","author":"Cosgrove","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2014.04.018_bib76","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1086\/596630","article-title":"Vancomycin heteroresistance and methicillin-resistant Staphylococcus aureus","volume":"199","author":"Deresinski","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.mayocp.2014.04.018_bib77","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1128\/AAC.47.10.3040-3045.2003","article-title":"Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods","volume":"47","author":"Liu","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.mayocp.2014.04.018_bib78","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for","volume":"44","author":"Tenover","year":"2007","journal-title":"Staphylococcus aureus. Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2014.04.018_bib79","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"issue":"19","key":"10.1016\/j.mayocp.2014.04.018_bib80","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.mayocp.2014.04.018_bib81","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/AAC.01602-07","article-title":"Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.mayocp.2014.04.018_bib82","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/340353","article-title":"Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"34","author":"Stevens","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.mayocp.2014.04.018_bib83","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/AAC.44.12.3408-3413.2000","article-title":"Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections","volume":"44","author":"Stevens","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.mayocp.2014.04.018_bib84","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1185\/03007990903454912","article-title":"Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis","volume":"26","author":"Bounthavong","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"10.1016\/j.mayocp.2014.04.018_bib85","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/AAC.46.8.2723-2726.2002","article-title":"Hematologic effects of linezolid: summary of clinical experience","volume":"46","author":"Gerson","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.mayocp.2014.04.018_bib86","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.mayocp.2014.04.018_bib87","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1592\/phco.27.8.1189","article-title":"Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome","volume":"27","author":"Narita","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.mayocp.2014.04.018_bib88","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","article-title":"The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2014.04.018_bib89","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate","volume":"50","author":"Cui","year":"2006","journal-title":"Staphylococcus aureus. Antimicrob Agents Chemother"},{"key":"10.1016\/j.mayocp.2014.04.018_bib90","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: Eosinophilic Pneumonia Associated With the Use of Cubicin (Daptomycin). August 4, 2010. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm220273.htm. Accessed January 14,\u00a02014."},{"issue":"suppl 5","key":"10.1016\/j.mayocp.2014.04.018_bib91","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/431675","article-title":"The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam","volume":"41","author":"Ellis-Grosse","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocp.2014.04.018_bib92","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning. September 27, 2013. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm369580.htm. Accessed October 11,\u00a02013."},{"issue":"8","key":"10.1016\/j.mayocp.2014.04.018_bib93","doi-asserted-by":"crossref","first-page":"e41870","DOI":"10.1371\/journal.pone.0041870","article-title":"Efficacy and safety of telavancin in clinical trials: a systematic review and meta-analysis","volume":"7","author":"Polyzos","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.mayocp.2014.04.018_bib94","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/655827","article-title":"Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection","volume":"51","author":"Corey","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2014.04.018_bib95","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.05738-11","article-title":"CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections","volume":"56","author":"Friedland","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 4","key":"10.1016\/j.mayocp.2014.04.018_bib96","first-page":"iv67","article-title":"Integrated safety summary of CANVAS 1 and 2 trials: phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections","volume":"65","author":"Corrado","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.mayocp.2014.04.018_bib97","unstructured":"Cubist Pharmaceuticals. Cubist Announces FDA Acceptance of Tedizolid New Drug Application With Priority Review. http:\/\/www.cubist.com\/news\/118-cubist_announces_fda_acceptance_of_tedizolid_new_drug_application_with_priority_review. Accessed December 30,\u00a02013."},{"issue":"6","key":"10.1016\/j.mayocp.2014.04.018_bib98","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jama.2013.241","article-title":"Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial","volume":"309","author":"Prokocimer","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.mayocp.2014.04.018_bib99","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/379015","article-title":"Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections","volume":"37","author":"Seltzer","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocp.2014.04.018_bib100","article-title":"Durata Therapeutics","year":"2013","journal-title":"Clinical trials"},{"key":"10.1016\/j.mayocp.2014.04.018_bib101","unstructured":"The Medicines Company. The Medicines Company announces positive results for SOLO II trial of oritavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSI) [news release]. http:\/\/ir.themedicinescompany.com\/phoenix.zhtml?c=122204&p=irol-newsArticle&ID=1834647&highlight=. Accessed December 23,\u00a02013."},{"issue":"2","key":"10.1016\/j.mayocp.2014.04.018_bib102","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3810\/hp.2011.04.391","article-title":"Optimizing delivery of care for patients with MRSA infection: focus on transitions of care","volume":"39","author":"McKinnon","year":"2011","journal-title":"Hosp Pract"},{"issue":"suppl 2","key":"10.1016\/j.mayocp.2014.04.018_bib103","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1086\/653520","article-title":"Outpatient parenteral antimicrobial therapy today","volume":"51","author":"Paladino","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"10.1016\/j.mayocp.2014.04.018_bib104","doi-asserted-by":"crossref","first-page":"S220","DOI":"10.1086\/653523","article-title":"Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic center","volume":"51","author":"Nguyen","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2014.04.018_bib105","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/j.jemermed.2012.11.050","article-title":"Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines","volume":"44","author":"Moran","year":"2013","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.mayocp.2014.04.018_bib106","unstructured":"Srinivasan A. CDC expert commentary: three steps to antibiotic stewardship. November 15, 2010. http:\/\/www.medscape.com\/viewarticle\/731784. Accessed March 4,\u00a02014."},{"key":"10.1016\/j.mayocp.2014.04.018_bib107","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2334-6-94","article-title":"A\u00a0new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay","volume":"6","author":"Desai","year":"2006","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2014.04.018_bib108","doi-asserted-by":"crossref","first-page":"317","DOI":"10.18553\/jmcp.2003.9.4.317","article-title":"Early switch and early discharge opportunities in intravenous vancomycin treatment of suspected methicillin-resistant staphylococcal species infections","volume":"9","author":"Parodi","year":"2003","journal-title":"J\u00a0Managed Care Pharm"},{"issue":"1","key":"10.1016\/j.mayocp.2014.04.018_bib109","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archinte.161.1.61","article-title":"Early discharge of infected patients through appropriate antibiotic use","volume":"161","author":"Eron","year":"2001","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2014.04.018_bib110","first-page":"345","article-title":"Adverse events among medical patients after discharge from hospital","volume":"170","author":"Forster","year":"2004","journal-title":"CMAJ"},{"issue":"9B","key":"10.1016\/j.mayocp.2014.04.018_bib111","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1016\/S0002-9343(01)00964-0","article-title":"Primary care physician attitudes regarding communication with hospitalists","volume":"111","author":"Pantilat","year":"2001","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2014.04.018_bib112","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jhm.228","article-title":"Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists","volume":"2","author":"Kripalani","year":"2007","journal-title":"J\u00a0Hosp Med"},{"issue":"8","key":"10.1016\/j.mayocp.2014.04.018_bib113","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jamainternmed.2013.3023","article-title":"Potentially avoidable 30-day hospital readmissions in medical patients: derivation and validation of a prediction model","volume":"173","author":"Donz\u00e9","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.mayocp.2014.04.018_bib114","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1525-1497.2004.30082.x","article-title":"Continuity of care and patient outcomes after hospital discharge","volume":"19","author":"Van Walraven","year":"2004","journal-title":"J\u00a0Gen Intern Med"},{"issue":"17","key":"10.1016\/j.mayocp.2014.04.018_bib115","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1001\/archinte.166.17.1822","article-title":"The care transitions intervention: results of a randomized controlled trial","volume":"166","author":"Coleman","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2014.04.018_bib116","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-150-3-200902030-00007","article-title":"A\u00a0reengineered hospital discharge program to decrease rehospitalization: a randomized trial","volume":"150","author":"Jack","year":"2009","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2014.04.018_bib117","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jama.281.7.613","article-title":"Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial","volume":"281","author":"Naylor","year":"1999","journal-title":"JAMA"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619614003814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619614003814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T04:02:04Z","timestamp":1538539324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619614003814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":117,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0025619614003814"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2014.04.018","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}